(c) ACT: a combination of artemisinin or one of its derivatives (e.g. artesunate, artemether) with another antimalarial of a different class. (d) If it is impossible to refer a patient to a center capable of providing parenteral treatment, rectal artesunate should be given according to the same schedule as artesunate slow IV injection (H0, H12, H24, then once daily). (e) Place a level teaspoon of sugar, moistened with a few drops of water, under the tongue, then place the patient in the recovery position. Repeat after 15 minutes if the patient has not regained consciousness. As with other methods for treating hypoglycaemia, maintain regular sugar intake, and monitor. References 1. World Health Organization. Guidelines for the treatment of malaria, 3rd ed. World Health Organization. 2015. https://apps.who.int/iris/handle/10665/162441 2. World Health Organization. Compendium of WHO malaria guidance: prevention, diagnosis, treatment, surveillance and elimination. 2019. https://apps.who.int/iris/handle/10665/312082 3. World Health Organization. WHO policy brief on single-dose primaquine as gametocytocide in Plasmodium falciparum malaria. 2015. https://www.who.int/malaria/publications/atoz/who_htm_gmp_2015.1.pdf?ua=1 4. World Health Organization. WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. 2012. https://www.who.int/malaria/publications/atoz/smc_policy_recommendation_en_032012.pdf?ua=1 Page 18 7/ 409